Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas.

about

Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas.

Item

http://www.wikidata.org/entity/Q41554686

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Propensity score matching anal ...... for nasopharyngeal carcinomas.

@en

type

Item

label

Propensity score matching anal ...... for nasopharyngeal carcinomas.

@en

prefLabel

Propensity score matching anal ...... for nasopharyngeal carcinomas.

@en

P1476

Propensity score matching anal ...... for nasopharyngeal carcinomas.

@en

P2093

Bao-Lin Qu

http://www.w3.org/2001/XMLSchema#string

Chuan-Bin Xie

http://www.w3.org/2001/XMLSchema#string

Hai-Xia Liu

http://www.w3.org/2001/XMLSchema#string

Jing Chen

http://www.w3.org/2001/XMLSchema#string

Jun Yang

http://www.w3.org/2001/XMLSchema#string

Lei Du

http://www.w3.org/2001/XMLSchema#string

Lin Ma

http://www.w3.org/2001/XMLSchema#string

Lin-Chun Feng

http://www.w3.org/2001/XMLSchema#string

Shou-Ping Xu

http://www.w3.org/2001/XMLSchema#string

Xin-Xin Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin

Treatment of nasopharyngeal carcinoma using simultaneous modulated accelerated radiation therapy via helical tomotherapy: a phase II study.

Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases.

Clinical study of nasopharyngeal carcinoma treated by helical tomotherapy in China: 5-year outcomes.

Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial.

Multimodality Treatment May Improve the Survival Rate of Patients with Metastatic Nasopharyngeal Carcinoma with Good Performance Status.

21 years of biologically effective dose

Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study

Treatment of nasopharyngeal carcinoma by tomotherapy: five-year experience.

The role of adjuvant chemotherapy in nasopharyngeal carcinoma with bulky neck lymph nodes in the era of IMRT.

P2888

s12885-017-3581-1

P304

582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-017-3581-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091370861

http://www.w3.org/2001/XMLSchema#string

P698

28851315

http://www.w3.org/2001/XMLSchema#string

P932

5575876

http://www.w3.org/2001/XMLSchema#string